0000950170-24-035939.txt : 20240325 0000950170-24-035939.hdr.sgml : 20240325 20240325161953 ACCESSION NUMBER: 0000950170-24-035939 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240321 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital VII, L.P. CENTRAL INDEX KEY: 0001750266 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40532 FILM NUMBER: 24779471 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures VII GP, L.P. CENTRAL INDEX KEY: 0001777655 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40532 FILM NUMBER: 24779470 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures VII GP-GP, LLC CENTRAL INDEX KEY: 0001777656 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40532 FILM NUMBER: 24779469 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LENZ Therapeutics, Inc. CENTRAL INDEX KEY: 0001815776 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 844867570 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE SUITE 320 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-925-7000 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVE SUITE 320 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: Graphite Bio, Inc. DATE OF NAME CHANGE: 20210312 FORMER COMPANY: FORMER CONFORMED NAME: Integral Medicines, Inc. DATE OF NAME CHANGE: 20200622 3 1 ownership.xml 3 X0206 3 2024-03-21 0 0001815776 LENZ Therapeutics, Inc. LENZ 0001750266 Versant Venture Capital VII, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 false false true false 0001777655 Versant Ventures VII GP, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 false false true false 0001777656 Versant Ventures VII GP-GP, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 false false true false Common Stock 1598789 D Warrant (Right to Buy) 10.64 2024-03-21 2027-10-30 Common Stock 70534 D These securities were acquired pursuant to that certain Agreement and Plan of Merger by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("Merger Sub"), and Lenz Therapeutics, Inc., a Delaware corporation ("LENZ"), pursuant to which the Merger Sub merged with and into LENZ (the "Merger"), with LENZ continuing as a wholly owned subsidiary of the Issuer and the surviving corporation of the Merger. These securities are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII disclaims beneficial ownership of the shares held by VVC VII, except to the extent of their respective pecuniary interests therein. Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 2024-03-25 Versant Ventures VII GP, L.P., By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 2024-03-25 Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 2024-03-25